Articles

Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;Department of Medicine, Division of Hematology, University of Washington, Seattle, WA;Department of Epidemiology, University of Washington, Seattle, WA
Stanford University, Stanford, CA
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
Stanford University, Stanford, CA
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;Department of Medicine, Division of Hematology, University of Washington, Seattle, WA
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;Department of Medicine, Division of Hematology, University of Washington, Seattle, WA
Vol. 99 No. 1 (2014): January, 2014 https://doi.org/10.3324/haematol.2013.096545